| Authors | Year | Title | Journal and link to the article |
| Hölter et al. | 2023 | Recommendations for robust and reproducible preclinical research in personalised medicine | BMC Medicine |
| Bespalov et al. | 2021 | Introduction to the EQIPD quality system | eLife |
| Bespalov A, Michel M, Steckler T (eds) | 2020 | Good Research Practice in Non-Clinical Pharmacology and Biomedicine | Springer |
| Arroyo-Araujo et al. | 2019 | Reproducibility via coordinated standardization: a multi-center study in a Shank2 genetic rat model for Autism Spectrum Disorders | Scientific Reports |
| Prager et al. | 2018 | Improving transparency and scientific rigor in academic publishing | Improving transparency and scientific rigor in academic publishing |
| Bespalov et al. | 2018 | Industry is more alarmed about reproducibility than academia | Nature |
| Bespalov & Steckler | 2018 | Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science? | Journal of Neuroscience Methods |
| Kokras et al. | 2017 | Kinoscope: An Open-Source Computer Program for Behavioral Pharmacologists. | Frontiers in Behavioral Neuroscience |
| Bespalov et al. | 2016 | Failed clinical trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets. | Nature Reviews Drug Discovery |
| Popp et al. | 2016 | In search of the mechanisms of ketamine’s antidepressant effects: How robust is the evidence behind the mTor activation hypothesis. | F1000Research |
| Steckler et al. | 2016 | Reporting guidelines for Psychopharmacology | Psychopharmacology |
| Steckler et al. | 2015 | The Preclinical Data Forum Network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience. | European Neuropsychopharmacology |
| Steckler | 2015 | Preclinical data reproducibility for R&D – the challenge for neuroscience | Psychopharmacology |
Menu